BRUSSELS (Reuters) – The European Union drug regulator will use data from Britain and other countries outside the EU on the safety of Pfizer-BioNTech’s COVID-19 vaccine before deciding whether to approve it, it said in a statement on Wednesday.
Britain’s medicine regulator has advised that people with a history of significant allergies do not get the Pfizer-BioNTech vaccine after two people reported adverse reactions on the first day of rollout on Wednesday.
Asked whether this new information could be used in the assessment of the vaccine in Europe, the European Medicines Agency said: “All available information on the quality, safety and efficacy of the vaccine will be taken into account. This will include safety data generated from the use of the vaccine outside the EU.”
(Reporting by Francesco Guarascio; Editing by Chizu Nomiyama)
